Imagen de Portada

Genetic Testing Among Black and White Patients With Advanced Prostate Cancer: A Retrospective Analysis of Testing Utilization and Referral Patterns

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Kyle C. McElyea, James P. Purtell, Avery K. Supernois, Courtney M. Rose, Farhan Ibrahim, Mohammed A. Baseer, Sunita Ghosh, Clara Hwang
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	The Prostate
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Socioeconomic and Demographic Factors in Genetic Testing Utilization Among Advanced Prostate Cancer Patients
por: Alexandra T. Skowron, et al.
Publicado: (2026)

Comprehensive Genomic Profiling Testing for Castration‐Resistant Prostate Cancer in Advanced Elderly Patients: A Single‐Center Retrospective Cohort Study
por: Takafumi Fukushima, et al.
Publicado: (2025)

Genetics‐Driven, Intensity‐Modulated Adaptive Management of Patients With Metastatic Prostate Cancer
por: Reynier D. Rodriguez Rosales, et al.
Publicado: (2025)

Mortality and Additional Treatment Rates in Pathologically High‐Risk Prostate Cancer With Prostate‐Specific Antigen Persistence at Robot‐Assisted Radical Prostatectomy: Long‐Term Report From Single Tertiary Referral Center
por: Alessandro Bertini, et al.
Publicado: (2025)

Microbial Differences in Prostate Lesions Between Black and White American Men
por: Shiv Verma, et al.
Publicado: (2026)

Safety and Efficacy of Intra‐Prostatic Injection of Betamethasone for Refractory Chronic Nonbacterial Prostatitis: A Prospective Cohort Clinical Study
por: Ahmed Yehia Abdelaziz, et al.
Publicado: (2024)

Racial Disparities in the Use of MRI and PET Scan Among Medicare Beneficiaries With Prostate Cancer
por: Hanna Zurl, et al.
Publicado: (2025)

The Effects of the Blood‐Based S2,3PSA% Test on Prostate Cancer Screening: A Novel Approach to Reduce the Need for MRI and Unnecessary Biopsies
por: Hikari Miura, et al.
Publicado: (2025)

Individualized Precision Prostate Biopsy Strategy for Patients With PI‐RADS Score 2: A Retrospective Multicenter Study
por: Zhiyao Xu, et al.
Publicado: (2025)

[ 18 F] PSMA PET‐CT and [ 18 F] Choline PET‐CT in the Diagnosis of High‐Risk Localized Prostate Cancer: Comparation of Both Tests
por: M. A. Tárraga‐Honrubia, et al.
Publicado: (2026)

Factors Associated With Male Breast Cancer Incidence Among Prostate Cancer Survivors: Real World Evidence From Veterans Affairs National Prostate Cancer Data Core
por: Erum Z. Whyne, et al.
Publicado: (2025)

Treatment Noncompletion and Shorter Radiation Regimens Among US Patients With Prostate Cancer: A Focus on Asian American and Pacific Islander Patients
por: Rohit V. Mantena, et al.
Publicado: (2025)

Effects of Concurrent Administration of Spironolactone in Veterans with Metastatic Prostate Cancer Receiving Abiraterone: A Real‐World Retrospective Study
por: Erum Z. Whyne, et al.
Publicado: (2024)

Comparative Effectiveness of First‐Line Treatments for Castration‐Resistant Prostate Cancer: A Large‐Scale Retrospective Study in Japan
por: Akihito Hashizume, et al.
Publicado: (2025)

Prostate Specific Antigen Density and Clinically‐Significant Prostate Cancer: The Influence of Prostatic Volume
por: Elizabeth Robinson, et al.
Publicado: (2025)

Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance
por: Marco Oderda, et al.
Publicado: (2025)

Global Trends in Prostate Cancer Incidence Among Men Aged 55+ (1992–2021): An Age‐Period‐Cohort Analysis
por: Xinling Han, et al.
Publicado: (2026)

Do Prostate Imaging‐Reporting and Data System (PIRADS) lesions predict holmium laser enucleation of prostate outcomes?
por: Kyle Tsai, et al.
Publicado: (2024)

Pathology of a Canine Model of Localized Prostate Carcinoma
por: Nathan K. Hoggard, et al.
Publicado: (2025)

Minimally Invasive Holmium Laser Enucleation of the Prostate (MiLEP) Vs. HoLEP: Retrospective Analysis of Perioperative Outcomes in a Propensity Score‐Matched Cohort
por: Jacob Schmidt, et al.
Publicado: (2025)

Enhancing Diagnostic Accuracy in Prostate Oncology: A Multidimensional Perspective on Prostate Specific Antigen Density
por: Shengyi Chen, et al.
Publicado: (2025)

Safety and Efficacy of Bipolar Transurethral Vaporization of the Prostate and Bipolar Transurethral Resection of the Prostate in the Management of Large Volume Benign Prostatic Hyperplasia: A Prospective Randomized Study
por: Amr M. Lotfy, et al.
Publicado: (2026)

The Prognostic Value of the Prostate Adenocarcinoma With Ductal Feature in Patients With Advanced Prostate Cancer Treated With Abiraterone Acetate
por: Yifu Shi, et al.
Publicado: (2025)

Assessment of Circulating Neuroendocrine Tumor Markers at Prostate Cancer Diagnosis: An Investigation of Prostate Cancer With Neuroendocrine Features
por: Tatsuya Shimomura, et al.
Publicado: (2026)

Discovering the Prostate: Notes on History and Historiography
por: Diederik F. Janssen
Publicado: (2025)

Evidence and Rationale for Prostate Cancer Screening
por: Takeshi Takahashi
Publicado: (2025)

Spatial Characteristics of Intraductal Carcinoma of the Prostate
por: Rodolphe Dupuis, et al.
Publicado: (2025)

Impact of Holmium Laser Enucleation of the Prostate on Active Surveillance for Prostate Cancer in Patients With Lower Urinary Tract Symptoms
por: Charly Bâcle, et al.
Publicado: (2025)

Prostatic Surgery With Preservation of the Supramonticular Tissue Versus Standard Surgery for Benign Prostatic Hyperplasia: A Systematic Review
por: Giuston Mendoza‐Chuctaya, et al.
Publicado: (2025)

Efficacy, Safety, and Cost‐Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non‐Metastatic Castration‐Resistant Prostate Cancer: A Multicenter Retrospective Study
por: Himawari Asanuma, et al.
Publicado: (2026)

Prostate‐Specific Antigen Response at Six Months Predicts Progression in Metastatic Hormone‐Sensitive Prostate Cancer Treated With Apalutamide
por: Christian Andrés Martínez Osorio, et al.
Publicado: (2025)

Prostate Extracellular Vesicles and Prognostic Biomarkers of Clinically Significant Prostate Cancer: A Prospective Single‐Institution Pilot Study
por: Cameron J. Britton, et al.
Publicado: (2025)

Current Status of Prostate Biopsy in Africa: Are We Ready for a Targeted Biopsy?
por: Ziba Ouima Justin Dieudonne, et al.
Publicado: (2025)

Mycobacterium Tuberculosis: The Hidden Bacteria in Chronic Prostatitis
por: André Avarese Figueiredo, et al.
Publicado: (2025)

Altered Glycosylation of PSA in Prostate Cancer Tissue
por: Hannu Koistinen, et al.
Publicado: (2025)

Castration Resistance Accelerates Prostate Cancer Kinetics
por: Sheila Jonnatan, et al.
Publicado: (2026)

CHARGE: The “Big Questions” in Prostate Cancer for 2024
por: Andrea K. Miyahira, et al.
Publicado: (2024)

Nectin‐4 Expression in Prostatic Adenocarcinoma: An Immunohistochemical Study
por: Ezra G. Baraban, et al.
Publicado: (2025)

Developments in Ultrasound‐Based Imaging for Prostate Cancer Detection
por: Reid Vassallo, et al.
Publicado: (2025)

Prostate Volume and PSA‐Density Estimation by Transabdominal Ultrasound: Prospective Evidence of Comparative Accuracy to MRI and Transrectal Ultrasound in Prostate Cancer Early Diagnostics
por: Liza M. Kurucz, et al.
Publicado: (2025)